Shortage in prescription drug supply possible

Posted in Latest News on January 19, 2017.

The DEA recently suspended McKesson Corporation’s sales of controlled substances from distribution in Florida. This suspension could impact your patients’ ability to fill their prescriptions and you may want to advise them about the potential implications. As a practitioner, you should be aware of the possibility of drug shortages and consider alternative treatment options when prescribing controlled substances. As always, use your best professional judgment when caring for your patients.

Please see the link to the news release below: https://www.dea.gov/divisions/hq/2017/hq011717.shtml



More Latest News

Urgent National Drug Shortage
October 16, 2017

Please Click for Details on the Urgent National Drug Shortage: Lidocaine with Epinephrine and Bupivacaine with Epinephrine Continue reading


Notices of Proposed Rulemaking
October 9, 2017

Prior to promulgation and adoption of a final rule or rules impacting the eNLC, the Interstate Commission shall file a notice of proposed rulemaking on the website of each Member Board. Continue reading